586 posters, 8 topics, 23 sessions, 1,077 authors, 622 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
ISQua's 40th International Conference 2024
24th - 27th September 2024 | Istanbul, Türkiye
ISQUA2024-ABS-3327
A Sustainable Health Technologies Innovation Model To Improve LRS Clinical Outcomes
Poster Presenter
Part of Topic
Future of Healthcare: AI and Digital Transformation
A Sustainable Health Technologies Innovation Model To Improve Low Resource Settings (LRS) Clinical Outcomes
Presenter: Stefano Bergamasco, GCEA Advisory Council, WHO Consultant
Co-Authors: Yadin David (GCEA President) & Tom Judd (GCEA Liaison Director)
Introduction
•Access to innovations in health technologies and the capacity to implement them locally is a pillar identified by the World Health Organization’s (WHO) healthcare delivery strategy.
•Health innovation aims to develop and deliver new/enhanced policies, systems, products, technologies, services, and delivery methods to improve health and clinical outcomes.
•Medical devices, oxygen sources, digital health tools, and personal protective equipment are defined as health technologies (HT) that have the potential to i
improve quality of life and health outcomes and improve efficacy.
•However, access to high quality, safe, appropriate, and affordable HT is not equitable, most severely in low resource settings (LRS).
Method
•The authors participated in two rapid WHO evidence-based assessments for innovations with a team that addressed the following assessment dimensions
•clinical
•specification comparison
•regulatory compliance
•technology evidence; health technologies and engineering management (authors’)
•and intellectual property and potential of local production.
resulting in two WHO Innovation Compendia published in 2021 and 2022.
•Our global professional organization GCEA contracted with WHO’s Medical Device Unit for these assessments and voluntarily engaged 100 reviewers from fifty LRS countries to collect on-the-ground evaluation of the various products for these two Compendia.
Results
•The 2022 Compendium presents manufacturer/developer-reported information and multidisciplinary assessment results of 15 Health Technologies. HT were classified as either commercially available (7), or prototypes (8).
•The Compendium sheds light on advantages and challenges associated with implementing innovative HT in LRS and can be used by governments, NGOs and other stakeholders to support adoption decisions.
•It also aims to foster greater collaboration between Ministries of Health, procurement officers, donors, technology developers, manufacturers, clinicians, academics, and the public to ensure increased investment in appropriate HT and a connected move toward access to essential HT.